The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Emalex Biosciences met primary and secondary endpoints in its Phase 3 registrational trial of ecopipam for patients with ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...

Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...

In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...

TikToker Baylen Dupree, who shares her life with Tourette Syndrome on social media, announced her engagement to Colin Dooley ...

Baylen Dupree was interviewed on the 'Not Skinny But Not Fat' podcast on Feb. 19 and revealed she doesn't get tics when she's ...

TLC will continue to follow Baylen Dupree’s journey as she navigates life with Tourette Syndrome as the network renewed ...

In April 2024, SciSparc and AutoMax signed a merger agreement under which SciSparc will acquire 100% of AutoMax, aiming to ...